Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses
Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses
Read moreFri, 27th Mar 2015 09:43
Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses
Read moreUPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid
Read moreNo Redx Pharma Takeover As Yesod Opts Not To Make Offer
Read moreUK Regulator Extends Deadline For Possible Redx Pharma Cash Offer
Read moreUK Regulator Extends Deadline For Possible Redx Pharma Cash Offer
Read moreMoulton Goodies Raises Stake In Redx Pharma To 42% From 18%
Read more(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of RXC007 as its next drug development candidate for the treatment of fibrosis on Thursday.
Read moreRedx Pharma Nominates Another Anti-Fibrosis Drug Candidate
Read moreUK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer
Read moreRedx Pharma Shares Soar On Discussions Over Possible Takeover Offer
Read moreLONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking
Read more(Sharecast News) - Redx Pharma announced on Tuesday that Innovate UK has awarded biomedical catalyst funding to Redx and Medicines Discovery Catapult (MCD).
Read moreRedx Pharma Secures Funding To Develop Lung Condition Therapies
Read more(Alliance News) - Redx Pharma PLC on Monday said it has successfully completed dosing of the first cohort of patients in its ongoing phase 1/2 study with RXC004.RXC004 is an oral porcupine
Read more(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.
Read more